Estrogenic effects of Sedum sarmentosum Bunge in ovariectomized rats

Journal of Nutritional Science and Vitaminology

Volumn 50, Issue 2, 2004, Pages 100-105

  Kim, Won Hee ^a   Park, Yun Ja ^a   Park, Mi Ra ^a   Ha, Tae Yeul ^b   Lee, Sang Hyeon ^a,c   Bae, Song Ja ^a,c   Kim, Mihyang ^a,c  

^a Silla University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Mar Biotech Ctr Bio Func Mat I   (South Korea)

Author keywords

Collagen; Estrogenic effects; Lipid; Ovariectomized rats; Sedum sarmentosum Bunge

Indexed keywords

ACETIC ACID ETHYL ESTER; COLLAGEN; ESTRADIOL; ETHER; LIPID; PLANT EXTRACT; SEDUM SARMENTOSUM EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; CARTILAGE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; CRASSULACEAE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID BLOOD LEVEL; MENOPAUSE; NONHUMAN; RAT; SEDUM SARMENTOSUM; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALIA; CRASSULACEAE; SEDUM; SEDUM SARMENTOSUM;

EID: 2442666299     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.50.100     Document Type: Article

References (48)

1. Brosage P. 1995. Hormone therapy: The woman's decision. Contemp Nurse Pract 1(S): 3.
2. Bush TL, Barret-Connor E. 1985. Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 7: 89-104.
3. Stolley PD, Tonascia JA, Tockman MS, Sartwell PE, Rutledge AH, Jacobs MP. 1975. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol 102: 197-201.
4. Harris RB, Laws A, Reddy FM, King A, Haskell WL. 1990. Are women using postmenopausal estrogens? A community survey. Am J Public Health 80: 1266-1268.
5. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Menson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. 1995. The use of estrogens and progenstins and the risk of breast cancer in postmenopausal women. New Engl J Med 332: 1589-1593.
6. Wickelgren I. 1997. A new weapon against Alzheimer's. Science 276: 676-677.
7. Grodstein F, Stamfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE. 1997. Postmenopausal hormone therapy and mortality. New Engl J Med 336: 1769-1775.
8. Kurzer MS, Xu X. 1997. Dietary phytoestrogens. Annu Rev Nutr 17: 353-381.
9. Anderson JJ, Garner SC, Mar MH, Boass A, Toverud SU, Pankh I. 1990. The ovariectomized lactating rat as an experimental model for osteopenia: Calcium metabolism and bone changes. Bone Miner 11: 43-53.
10. Calu DN, Hardin RR, Cockerham R. 1989. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 124: 7-16.
11. Omi K, Ezawa I. 1995. The effect of ovariectomy on bone metabolism in rats. Bone 17(Suppl): 163S-168S.
12. Yamazaki I, Yamaguchi H. 1989. Characteristics of an ovariectomized osteopenic rat model. J Bone Miner Res 4: 13-22.
13. Kannel WB, Hjortland MC, McNamara PM, Gordon T. 1976. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85: 447-452.
14. Wenger NK, Speroff L, Packard N. 1993. Cardiovascular health and disease in women. N Engl J Med 329: 247-256.
15. Stampfer MJ, Colditz GA. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: 47-63.
16. Mizutani K, Ikeda K, Kawai Y, Yamori Y. 2000. Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol 46: 78-83.
17. Stevenson JC, Crook D, Godsland IF. 1993. Influence of age and menopause on serum lipid and lipoproteins in healthy women. Atherosclerosis 98: 83-90.
18. Kafantari H, Kounadi E, Fatouros M, Milonakis M, Tzaphlidou M. 2000. Structural alteration in rat skin and bone collagen fibrils induced by ovariectomy. Bone 26: 349-353.
19. McConkey B, Fraser GM, Bligh AS, Whiteley H. 1963. Transparent skin and osteoporosis. Lancet 1: 693-695.
20. Fountos G, Kounadi E, Tzaphlidou M, Yasumura S, Glaros D. 1998. The effects of inflammation-mediated osteoporosis (IMO) on the skeletal Ca/P ratio and on the structure of rabbit bone and skin collagen. Appl Radiat Isot 49: 657-659.
21. Lovett CR, Smolensky KA, Duance VC, Light ND, Young S, Dyson M. 1987. Type I and III collagen content and fibre distribution in normal human skin during aging. Br J Dermatol 117: 419-428.
22. Miyamoto NG, Moncollin V, Egly JM, Chambon P. 1985. Specific interaction between a transcription factor and the upstream element of the adenovirus-2 major late promoter. EMBO J 4: 3565-3570.
23. Ponglikitmongkol M, White JH, Chambon P. 1990. Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. EMBO J 9: 2221-2231.
24. Fujimoto D, Moriguchi T. 1978. Pyridinoline, a non-reducible crosslink of collagen. J Biochem 83: 863-867.
25. Woessner JF. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93: 440-447.
26. Cotton P. 1994. Environmental estrogenic agents area of concern. JAMA 271: 414-416.
27. Safe SH. 1995. Environmental and dietary estrogens and human health: Is there a problem? Environ Health Perspect 103: 346-351.
28. Feldman D. 1997. Estrogens from plastic-Are we being exposed? Endocrinology 138: 1777-1779.
29. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. 1995. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 332: 1589-1593.
30. Henderson BE, Ross R, Bernstein L. 1998. Estrogen as a cause of human cancer. The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 48: 246-253.
31. Liehr JG. 1990. Genotoxic effects of estrogens. Mutat Res 238: 269-276.
32. Stampfer MJ, Willett WC, Hunter DJ, Manson JE. 1992. Type of postmenopausal hormone use and risk of breast cancer: 12-year follow-up from the Nurses' Health Study. Cancer Causes Control 3: 33-39.
33. Bolton JL, Pisha E, Zhang F, Qiu S. 1998. Role of quinoids in estrogen carcinogenesis. Chem Res Toxicol 11: 1113-1127.
34. Setchell KDR. 1998. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333S-1346S.
35. Setchell KDR, Cassidy A. 1999. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 129: 758S-767S.
36. Murkies AL, Wilcox G, Davis SR. 1998. Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 83: 297-303.
37. Zava DT, Dollbaum CM, Blen M. 1998. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 217: 369-378.
38. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. 1996. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126: 161-167.
39. Wade GN. 1975. Some effects of ovarian hormones on food intake and body weight in female rats. J Comp Physiol Psychol 88: 183-193.
40. Jones AP, McElroy JF, Crnic L, Wade GN. 1991. Effects of ovariectomy in thermogenesis in brown adipose tissue and liver in Syrian hamsters. Physiol Behav 50: 41-45.
41. Kikuchi-Hayakawa H, Onodera N, Matsubara S, Yasuda E, Shimakawa Y, Ishikawa F. 1998. Effect of soya milk and Bifidobacterium-fermented soya milk on plasma and liver lipids, and faecal steroids in hamsters fed on a cholesterol-free or cholesterol-enriched diet. Br J Nutr 79: 97-105.
42. Barrett-Connor E, Bush TL. 1991. Estrogen and coronary heart disease in women. JAMA 265: 1861-1867.
43. Wenger NK, Speroff L, Packard B. 1993. Cardiovascular health and disease in women. N Engl J Med 329: 247-256.
44. Kikuchi-Hayakawa H, Onodera N, Matsubara S, Yasuda E, Chonan O, Takahashi R, Ishikawa E 1998. Effects of soy milk and Bifidobacterium fermented soy milk on lipid metabolism in aged ovariectomized rats. Biosci Biotechnol Biochem 62: 1688-1692.
45. Kikuchi-Hayakawa H, Onodera-Masuoka N, Kano M, Matsubara S, Yasuda E, Takahashi R, Ishikawa F. 2000. Effects of soy milk and Bifidobacterium fermented soy milk on plasma and liver lipids in ovariectomized Syrian hamsters. J Nutr Sci Vitaminol 46: 105-108.
46. Sato M, Rippy MK, Bryant HU. 1996. Raloxifene, ramoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats. FASEB J 10: 905-912.
47. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. 1991. Estrogen monotherapy and combinated estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 87: 1274-1279.
48. Bailey AJ, Wotton SF, Sims TJ, Thompson PW. 1992. Post-translational modifications in the collagen of human osteoporotic femoral head. Biochem Biophys Res Commun 185: 801-805.